Subject Area and Research Team: IX. Cancer prevention and early detection

Subject Area and Research Team: IX. Cancer prevention and early detection

Research topics

1. Identification and characterization of cancer environmental risk factors

2. Application of modern imaging methods in early diagnostics of precancerous conditions and malignancy (narrow band imagining, videodermoscopy, confocal microscopy)

3. Studies on genetic cancer predisposition

Key current projects

1. Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection of smoking cessation after diagnosis of cancer

2. Testis microlithasis as precancerous lesions in the development of germ cell tumours in children

3. Identification of new dermoscopic markers and their utility in primary and secondary skin cancer prevention

4. Exposure to endocrine disrupting chemicals and the risk of hormone dependent cancers


Coordinator #1 Coordinator #2 Coordinator #3
Name and surname
Michał Sobjanek
Bogusław Mikaszewski
Łukasz Balwicki
Academic degree Dr. Habil. Dr. Habil. Dr. Habil., Assoc. Prof.
Employment unit Department of Dermatology, Venereology and Allergology Department of Otolaryngology Division of Public Health & Social Medicine
Polish Platform of Medical Research Dr. Habil. Michał Sobjanek Dr. Habil. Bogusław Mikaszewski Dr. Habil. Łukasz Balwicki, Assoc. Prof.
Phone number +48 58 349 40 10 +48 58 349 31 10 +48 58 349 25 40

photos Paweł Sudara/MUG, Sylwia Mierzewska/UCC

Research Team: IX. Cancer prevention and early detection

Team Members: IX. Cancer prevention and early detection (163 KB)

Feel free to contact one of our coordinators to join our Research Team.

Key grants

Funding agency/grant number Title of the project Years
1. National Science Centre Radiomic and metabolomic signatures of early lung cancer 2018-2021
2. „Horizon 2020 – the Framework Programme for Research and Innovation” ERA-NET TRANSCAN/01/2019. Validation of multiparametric models and circulating and imaging biomarkers to improve lung cancer early detection 2014-2020

International cooperation

Foreign partner (unit name) Principal investigator(s) Area of cooperation
1. International Association for the Study of Lung Cancer (IASLC) Ugo Pastorino Diagnostics and treatment of early lung cancer, lung cancer screening
2. Division of Radiotherapy, IEO European Institute of Oncology, IRCCS, Milan, Italy Barbara Alicja Jereczek-Fossa Signalling pathways in head and neck cancer
3. Aristotle University, Thessaloniki, Greece Aimilios Lallas Mucoscopy as an emerging tool in the diagnostics of oral pathology

Key publications

1. Rzyman W, Szurowska E, Adamek M. Implementation of Lung Cancer Screening at The National Level: Polish Example. Transl Lung Cancer Res 2019; vol. 8: p. 95-105.

2. Pedersen J, Rzyman W, Veronsei G, D’amico T, Van Schil P, Molins L, Massard G Et al. Recommendations from The European Society of Thoracic Surgeons (Ests) Regarding Computed Tomography Screening for Lung Cancer In Europe. Eur J Cardio-Thorac Surg 2017; vol. 51: p. 411-420.

3. Ros-Mazurczyk M, Jelonek K, Marczyk M, Binczyk F, Pietrowska M, Polanska J, Dziadziuszko R, Jassem J, Rzyman W, Widlak P. Serum lipid profile discriminates patients with early lung cancer from healthy controls. Lung Cancer. 2017; vol. 112: p. 69-74.

4. Widlak P, Pietrowska M, Polanska J, Marczyk M, Ros-Mazurczyk M, Dziadziuszko R, Jassem J, Rzyman W. Serum mass profile signature as a biomarker of early lung cancer. Lung Cancer. 2016; vol. 99: p. 46-52.

5. Sławińska M, Zabłotna M, Gleń J, Lakomy J, Nowicki RJ, Sobjanek M. STAT3 polymorphisms and IL-6 polymorphism are associated with the risk of basal cell carcinoma in patients from northern Poland. Arch Dermatol Res. 2019; vol. 311: p. 697-704.